Linmiao Jiang

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Martin Dreyling, Jeanette K. Doorduijn, Eva Giné et al. · The Lancet · 2024 · 104 citations · Full text

Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

Martin Dreyling, Jeanette K. Doorduijn, Eva Giné et al. · Blood · 2022 · 84 citations

Lymphoid Neoplasia, Cell Therapy, Transplantation +11

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

Gabriel Scheubeck, Linmiao Jiang, Olivier Hermine et al. · Leukemia · 2023 · 48 citations · Full text

Comparative analysis of toxicity reduction of wastewater in twelve industrial park wastewater treatment plants based on battery of toxicity assays

Yue Yu, Bing Wu, Linmiao Jiang et al. · Scientific Reports · 2019 · 46 citations · Full text

High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network

Olivier Hermine, Linmiao Jiang, Jan Walewski et al. · Journal of Clinical Oncology · 2022 · 45 citations · Full text